Cite Filings / ORIC / 0001193125-22-081609

Feed Companies Filings Check

Sign in

POS AM

Post-effective Amendment for Registration Statement

Oric Pharmaceuticals, Inc. Filed 2022-03-22 Acc 0001193125-22-081609

Documents 1

POS AM Post-effective Amendment for Registration Statement , d335824dposam.htm

Around this filing

2022-03-25 4 President and CEO bought 350,000 shares at an average $4.92 ($1,723,708)
2022-03-22 S-8 Securities Offered to Employees in Benefit Plans
2022-03-22 POS AM Post-effective Amendment for Registration Statement
2022-03-21 8-K Regulation FD disclosure
2022-03-21 8-K Results of operations
2022-03-21 POSASR POSASR
2022-03-21 10-K Annual Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d335824dposam.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…